With continued progress and published results in the study of breast cancer, keeping up with the latest breakthroughs can be challenging. Below is the CancerConnect news coverage of the key developments of 2015.
Breast Cancer Screening and Prevention News
- The National Consortium of Breast Centers (NCBC) on American Cancer Society’s Breast Cancer Screening Recommendations
- Blood Test May Predict Cancer Recurrences Earlier than Standard Methods
- The Importance of Awareness of Breast Density and Its Impact on Cancer Screening and Risk
- Low-Fat Diet May Help Prevent Certain Breast Cancers
Genetics and Breast Cancer
- Roswell Park Cancer Institute Experts Discuss What it Means to be at High-Risk for Breast Cancer
- Ask the Expert: The Latest in Genetics and Women’s Cancers
- Hereditary Breast and Ovarian Cancer: What You Need To Know About Risk and Prevention
Breast Cancer Survivorship
Early Stage Breast Cancer: Surgery, Radiation & Chemotherapy
- Breast Cancer Research and Treatment Publishes Oncotype DX® DCIS Score™ Study Conducted in Canada
- Low Oncotype® Recurrence Score® Identifies Group of Women with Early Stage Breast Cancer That Can Avoid Chemotherapy
- Radiation Essential to Controlling Long-Term Recurrence in Women With Early Form of Breast Cancer
- Breast cancer treatment with fewer potential side effects has equally good patient outcomes, UCLA study shows
- Most Women with Early-Stage Breast Cancer Avoid Extensive Lymph Node Removal, Showing Increasing Adherence to Scientific Evidence that a Radical Operation Is No Longer Necessary
- Dose-Dense Chemotherapy with Ellence®, Cytoxan®, and Taxol® May Improve Survival in Node-Positive Breast Cancer
- Women with Early Breast Cancer Have Fewer Side Effects with Shorter Courses of Radiation
Hormone Receptor Positive Breast Cancer
- The Type of Breast Cancer Determines Effectiveness of Different Hormonal Therapies
- Palbociclib/Letrozole Improves Outcomes of Estrogen Receptor–Positive/HER2-Negative Advanced Breast Cancer
- Quality of Life Helps Determine Type of Hormone Treatment in Early Breast Cancer
- Arimidex® More Effective than Tamoxifen in Prevention of Recurrence in Early Breast Cancer
- Combination of Ibrance® Plus Faslodex® Promising in Advanced Hormone-Positive Breast Cancer
- Study Suggests Faslodex® Could Become New Standard First-Line Treatment of Metastatic Breast Cancer
- Novel Small Molecule Pictilisib May Benefit Women with Advanced Breast Cancer
- Abemaciclib Receives FDA Breakthrough Therapy Designation in Advanced Breast Cancer
- Hormone Drug Arimidex®(Anastrozole) Cuts Postmenopausal Breast Cancer Risk By Half
HER2-Positive Breast Cancer
- Afinitor® plus Herceptin® and Paclitaxel Effective in Advanced Hormone Receptor-Negative HER2-Positive Breast Cancer
- Conjugate Drug Extends Survival in Patients with Advanced HER2-Positive Breast Cancer
- Herceptin Superior to Tykerb for Treatment of HER2-positive Breast Cancer
Triple-Negative Breast Cancer
- No Benefit with Addition of Onartuzumab to Taxol® with or without Avastin® in Triple-Negative Breast Cancer
- Atezolizumab Plus Abraxane Promising New Treatment for Triple-Negative Breast Cancer
- Adding Carboplatin to Pre-surgery Chemotherapy Improves Survival for Patients with Triple-Negative Breast Cancer
- Radiation After Lumpectomy Improves Outcomes Among Elderly with Triple-Negative Breast Cancer
- A Vegan or Vegetarian Diet May Help Improve Treatment of Triple-Negative Breast Cancer
- Biomarker May Help Improve Treatment of Triple-Negative Breast Cancer
- Combination of Iniparib, Gemzar®, and Carboplatin Active in Initial Treatment of Early-Stage Triple-Negative Breast Cancer
- Platinum-Based Chemotherapy Active in Metastatic Triple-Negative Breast Cancer
LEARNING MORE ABOUT BREAST CANCER
Knowledge is power. Are you facing a new diagnosis, recurrence, living with metastatic disease, or supporting a loved one through their cancer journey?
- Sign up for monthly newsletters on breast cancer here.
- Get the facts about breast cancer here.
- Join ongoing discussions with other individuals affected by breast cancer in the CancerConnect private online support group here.
- Follow CancerConnect on Facebook and Twitter.
Copyright © 2018 CancerConnect. All Rights Reserved.